Ca<sup>2+</sup> Channel Toolkit in ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
Titre :
Ca<sup>2+</sup> Channel Toolkit in Neuroendocrine Tumors
Auteur(s) :
Fiorio Pla, Alessandra [Auteur]
Rôle des canaux ioniques membranaires et du calcium intracellulaire dans la physiopathologie de la prostate
Gkika, Dimitra [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Université de Lille
Rôle des canaux ioniques membranaires et du calcium intracellulaire dans la physiopathologie de la prostate
Gkika, Dimitra [Auteur]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Université de Lille
Titre de la revue :
Neuroendocrinology
Pagination :
147-154
Éditeur :
Karger
Date de publication :
2020-06-10
ISSN :
0028-3835
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Neuroendocrine tumors (NET) constitute a heterogeneous group of malignancies with various clinical presentations and growth rates but a common origin in neuroendocrine cells located all over the body. NET are a relatively ...
Lire la suite >Neuroendocrine tumors (NET) constitute a heterogeneous group of malignancies with various clinical presentations and growth rates but a common origin in neuroendocrine cells located all over the body. NET are a relatively low-frequency disease mostly represented by gastroenteropancreatic (GEP) and bronchopulmonary tumors (pNET); on the other hand, an increasing frequency and prevalence have been associated with NET. Despite great efforts in recent years, the management of NET is still a critical unmet need due to the lack of knowledge of the biology of the disease, the lack of adequate biomarkers, late presentation, the relative insensitivity of imaging modalities, and a paucity of predictably effective treatment options. In this context Ca<sup>2+</sup> signals, being pivotal molecular devices in sensing and integrating signals from the microenvironment, are emerging to be particularly relevant in cancer, where they mediate interactions between tumor cells and the tumor microenvironment to drive different aspects of neoplastic progression (e.g., cell proliferation and survival, cell invasiveness, and proangiogenetic programs). Indeed, ion channels represent good potential pharmacological targets due to their location on the plasma membrane, where they can be easily accessed by drugs. The present review aims to provide a critical and up-to-date overview of NET development integrating Ca<sup>2+</sup> signal involvement. In this perspective, we first give an introduction to NET and Ca<sup>2+</sup> channels and then describe the different families of Ca<sup>2+</sup> channels implicated in NET, i.e., ionotropic receptors, voltage-dependent Ca<sup>2+</sup> channels, and transient receptor potential channels, as well as intracellular Ca<sup>2+</sup> channels and their signaling molecules.Lire moins >
Lire la suite >Neuroendocrine tumors (NET) constitute a heterogeneous group of malignancies with various clinical presentations and growth rates but a common origin in neuroendocrine cells located all over the body. NET are a relatively low-frequency disease mostly represented by gastroenteropancreatic (GEP) and bronchopulmonary tumors (pNET); on the other hand, an increasing frequency and prevalence have been associated with NET. Despite great efforts in recent years, the management of NET is still a critical unmet need due to the lack of knowledge of the biology of the disease, the lack of adequate biomarkers, late presentation, the relative insensitivity of imaging modalities, and a paucity of predictably effective treatment options. In this context Ca<sup>2+</sup> signals, being pivotal molecular devices in sensing and integrating signals from the microenvironment, are emerging to be particularly relevant in cancer, where they mediate interactions between tumor cells and the tumor microenvironment to drive different aspects of neoplastic progression (e.g., cell proliferation and survival, cell invasiveness, and proangiogenetic programs). Indeed, ion channels represent good potential pharmacological targets due to their location on the plasma membrane, where they can be easily accessed by drugs. The present review aims to provide a critical and up-to-date overview of NET development integrating Ca<sup>2+</sup> signal involvement. In this perspective, we first give an introduction to NET and Ca<sup>2+</sup> channels and then describe the different families of Ca<sup>2+</sup> channels implicated in NET, i.e., ionotropic receptors, voltage-dependent Ca<sup>2+</sup> channels, and transient receptor potential channels, as well as intracellular Ca<sup>2+</sup> channels and their signaling molecules.Lire moins >
Langue :
Anglais
Comité de lecture :
Oui
Audience :
Internationale
Vulgarisation :
Non
Collections :
Source :
Fichiers
- 501397
- Accès libre
- Accéder au document